Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients [9]

Clinical Infectious Diseases

Volumn 42, Issue 6, 2006, Pages 893-895

  Carvalho, A C C ^a   De Iaco, G ^a   Saleri, N ^a   Pini, A ^a   Capone, S ^a   Manfrin, M ^a   Matteelli, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; STEROID; TUBERCULOSTATIC AGENT;

BACTERIUM CULTURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INGUINAL LYMPH NODE; LETTER; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; STEROID THERAPY; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HIV SERONEGATIVITY; HUMANS; ITALY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE;

EID: 33644845809     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/500459     Document Type: Letter

References (5)

1. Hawkey CR, Yap T, Pereira I, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 2005; 40:1368-71.
2. Vidal CG, Fernández SR, Lacasa JM, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 2005; 40:756-9.
3. Cheng V, Ho P, Lee R, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21:803-9.
4. Breen RA, Smith CJ, Bettinson H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV coinfection. Thorax 2004; 59:704-7.
5. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Resp Crit Care Med 1998; 158:157-61.